The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine -- causing sharp ...

The FDA approved darolutamide (Nubeqa) for metastatic castration-sensitive prostate cancer (mCSPC). The agency previously ...

In the wake of recent warnings from the Food and Drug Administration (FDA), about half of Americans think vaccines against ...

The shift indicates that critics' efforts to build support by releasing data on the harmful effects of the COVID-19 vaccines ...

The shot, dubbed mNexspike, is approved for older adults and people whose health conditions put them at higher risk of severe ...

Pfizer and Moderna's COVID-19 vaccines must now include updated warnings to highlight a rare risk of heart inflammation in teen boys and young men. HealthDay News — The U.S. Food and Drug ...

The FDA is also expanding its warning that some vaccines are linked to a risk of heart inflammation in young men.

The Food and Drug Administration ... also includes an updated warning regarding the increased risk of myocarditis and pericarditis with mRNA COVID-19 vaccines. The mNexspike vaccine is supplied ...